SciDev.Net

Some scientists worry that renewed enthusiasm for malaria eradication could distract from vital control efforts, says Priya Shetty.

A UNITAID patent pool could revolutionise HIV treatment and research in developing countries — if payment can be agreed, says Priya Shetty.

Countries need to produce their own vaccines, and they need to invest in public sector capacity to do it, says Indian scientist Y. Madhavi.

Swine flu vaccines should be equally available, regardless of a country's ability to pay, says medical expert Tadataka Yamada.

Policymakers must think outside the box to strengthen clinical research networks for global health, says Harvard researcher Jeff Blander.

More research is needed on how to tackle HIV with antiretroviral therapy, say Kevin M De Cock and colleagues at the WHO.

A lack of political will to create vaccines is causing millions of deaths a year due to infectious diseases, says Manuel Elkin Patarroyo.

New technologies can help African countries identify counterfeit or substandard drugs, says director of Africa Fighting Malaria Roger Bate.

International bodies, governments and indigenous people must all help protect medicinal biodiversity, say Jeffrey A. McNeely and Sue Mainka.

The biotech industry has advantages over pharma for drug discovery for neglected diseases, say Joanna E. Lowell and Christopher D. Earl.

GlaxoSmithKline plans to cut medicine prices and create a 'patent pool' — but does any of this reflect a real drive to boost the health of the poor?

New and existing HIV/AIDS treatments provide hope that the disease can be eliminated, says an editorial in New Scientist.

To sustain the fight against insect-borne diseases we must improve research funding for public health insecticides, says Roger Bate.

FDA priority review vouchers will not necessarily encourage research into tropical diseases, argues Aaron Kesselheim.

Developing biomedical research in China poses a massive challenge, says Zhu Chen.

Funding agencies and donors hoping to tackle malaria must commit more to basic research, says Nature.

Multidrug-resistant TB needs more research to equip healthcare workers with the right tools, write Frank G. J. Cobelens and colleagues.

Tadataka Yamada, Alice Dautry and Mark Walport want to see better coordination and financing for a global H5N1 virus vaccine stockpile.

Researchers are putting women's lives at risk by being too cautious about trialling drugs during pregnancy, say Nicholas J. White and colleagues.

Weaknesses in HIV research design have hindered progress in identifying prevention strategies, say Stephen W. Lagakos and Alicia R. Gable.